Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals Inc | Director | Common Stock | 65K | $1.19M | $18.27 | Feb 7, 2024 | Direct |
BICYCLE THERAPEUTICS plc | Director | Ordinary Shares | 33.5K | $586K | $17.50 | Jan 2, 2024 | Direct |
BICYCLE THERAPEUTICS plc | Director | Stock Option (right to buy) | 24K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | Feb 7, 2024 | 1 | $0 | 4 | Feb 9, 2024 | Director |
BCYC | BICYCLE THERAPEUTICS plc | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director |
SNDX | Syndax Pharmaceuticals Inc | Feb 2, 2023 | 1 | $0 | 4 | Feb 3, 2023 | Director |
SNDX | Syndax Pharmaceuticals Inc | Jan 12, 2023 | 9 | -$616K | 4 | Jan 13, 2023 | Director |
BCYC | BICYCLE THERAPEUTICS plc | Jan 3, 2023 | 2 | $0 | 4 | Jan 5, 2023 | Director |
SNDX | Syndax Pharmaceuticals Inc | Aug 5, 2022 | 6 | -$331K | 4 | Aug 9, 2022 | Director |
SNDX | Syndax Pharmaceuticals Inc | Feb 2, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Director |
BCYC | BICYCLE THERAPEUTICS plc | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Director |
BCYC | BICYCLE THERAPEUTICS plc | Dec 20, 2021 | 9 | -$7.38M | 4 | Dec 22, 2021 | Director |
SNDX | Syndax Pharmaceuticals Inc | Dec 20, 2021 | 6 | -$618K | 4 | Dec 22, 2021 | Director |